Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

DKAM Donville Kent Asset Management's investment thesis on Cipher Pharmaceuticals Inc. ($CPH.TO) — Q4 2024 | Buyside Digest

$CPH.TONASDAQCipher Pharmaceuticals Inc.

BULL

DKAM Donville Kent Asset Management—CPH.TO

Fund Letter

Q4 2024

Published December 31, 2024

$17.70USD

+23.4% vs last month

$14.42Pitched

+22.7% since pitch

Market CapN/A

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Cipher acquired Natroba, doubling the business size and gaining a direct US sales footprint. Internalizing distribution and...

— Jason & Jesse

BSD Research Exclusive

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

Other investors who've written on Cipher Pharmaceuticals Inc.

No other institutional pitches found for this ticker yet.